| Breakdown | TTM | Apr 2025 | Apr 2024 | Feb 2023 | Feb 2022 | Feb 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 36.14B | 36.10B | 37.05B | 37.64B | 38.00B | 37.29B |
| Gross Profit | 19.52B | 19.58B | 20.00B | 20.12B | 19.75B | 18.04B |
| EBITDA | 2.12B | 2.13B | 2.74B | 3.49B | 3.29B | 1.93B |
| Net Income | 705.00M | 701.00M | 1.40B | 1.89B | 1.70B | 263.00M |
Balance Sheet | ||||||
| Total Assets | 18.25B | 19.38B | 21.88B | 21.86B | 20.13B | 18.92B |
| Cash, Cash Equivalents and Short-Term Investments | 6.93B | 8.00B | 10.71B | 11.35B | 10.55B | 8.02B |
| Total Debt | 94.00M | 52.00M | 46.00M | 7.00M | 13.00M | 19.00M |
| Total Liabilities | 3.87B | 4.34B | 4.22B | 4.85B | 4.29B | 4.12B |
| Stockholders Equity | 14.38B | 15.04B | 17.66B | 17.01B | 15.83B | 14.80B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 751.00M | 383.00M | 1.91B | 3.53B | 926.00M |
| Operating Cash Flow | 0.00 | 1.75B | 1.41B | 2.55B | 3.74B | 1.15B |
| Investing Cash Flow | 0.00 | -2.95B | -1.15B | -699.00M | -418.00M | -433.00M |
| Financing Cash Flow | 0.00 | -905.00M | -895.00M | -1.05B | -789.00M | -789.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥164.17B | -70.02 | ― | 1.39% | 2.98% | 0.84% | |
68 Neutral | ¥15.12B | 2.44 | ― | 3.17% | 5.54% | 1.69% | |
65 Neutral | ¥27.55B | 10.33 | ― | 3.23% | 0.38% | -41.74% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | ¥125.63B | 14.71 | ― | 3.02% | 3.24% | -7.55% | |
61 Neutral | ¥49.66B | 3.77 | ― | 0.52% | 1.84% | -0.45% | |
60 Neutral | ¥12.11B | 7.69 | ― | 4.65% | 4.73% | -36.96% |